Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

26 Jul 2022 11:30

RNS Number : 7813T
Unicorn AIM VCT PLC
26 July 2022
 

Unicorn AIM VCT plc ("the Company")

Interim Management Statement

For the period from 1 April 2022 to 30 June 2022

 

Introduction

 

This voluntary Interim Management Statement (IMS) covers the three-month period ended 30 June 2022, together with relevant information up to the date of publication. 

 

Investment Objective

 

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust ("VCT"), so that Shareholders benefit from the taxation advantages that this brings. To achieve this, at least 80% of the Company's total assets are to be invested in qualifying investments of which 70% by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares, which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance

 

Net asset value per share continued to decline during the period under review. The performance of equity markets overall was also weak, as the war in Ukraine continued and the outlook for economic growth deteriorated further. As at 30 June 2022, the unaudited net asset value was 178.9 pence per share, which represents a decrease of 8.6% on the unaudited closing net asset value of 195.7 pence per share as at 31 March 2022.

 

By comparison, the FTSE AIM All-Share Total Return Index declined by 15.6%, while the FTSE All-Share Index (ex. Investment Trusts) declined by 4.6% over the same period.

 

The performance of the Company's diverse portfolio of investments has been relatively resilient throughout the period, although the de-rating of certain sectors such as life sciences and biotechnology has been particularly harsh, which has resulted in a significant decline in the market value of our investee companies that operate in these particular areas. Encouragingly however, the vast majority of the businesses in which the Company holds investments are well-financed and are therefore equipped to withstand an extended period during which the funding environment may remain challenging. The Company also has limited exposure to businesses dependent upon consumer spending, which further insulated the portfolio from the worst of the equity market falls experienced during the period under review. 

 

In addition, toward the end of the period, an unusually high proportion of total net asset value was held in cash. This elevated cash level was predominantly due to the receipt of proceeds from the sale of the Company's stake in Interactive Investor, whose acquisition by abrdn finally completed during the period. The significant cash proceeds received have therefore helped the performance.

 

Following the fully subscribed Offer for Subscription, which closed at the end of March 2022, we now have cash available to deploy in those investment opportunities that pass our due diligence process. It is important however, to remind Shareholders, that the new capital raised will, by regulatory necessity, be targeted at younger, less well-established businesses. Early stage, scale-up businesses are typically loss-making and cash consumptive and therefore present considerable risk to the investor.

 

Deal-flow declined markedly during the period, as management teams chose to delay or defer plans to list their businesses on the Alternative Investment Market (AIM). As a result of this reduced deal-flow and, in anticipation that equity markets were likely to remain weak, the Investment Manager decided to be even more selective than usual in regard to committing shareholder funds to new investment opportunities. As a result, no new investments were made during the period under review.

 

In the current inflationary environment, our ability to provide scale-up capital has become more crucial than ever for businesses that are in the early stages of their development, however it should again be emphasised that not all of our investee companies will ultimately be successful. We are therefore likely to remain cautious when it comes to deploying shareholder capital until there is better evidence of economic and equity market stability.

 

Despite the increased risks associated with early-stage investment and the uncertainty created by the re-emergence of inflation, your Investment Manager is confident that the portfolio, as a whole, remains well-positioned to deliver attractive total returns over the longer term.

 

Material Transactions

 

As previously noted, the Company's holding in Interactive Investor Limited was sold in its entirety during the period, realising proceeds of £55.1 million and crystallising a capital profit on disposal of £51.6 million.

 

Top Ten VCT Qualifying Holdings as at 30 June 2022

 

Stock

% of Total Assets

Hasgrove

7.3

Tracsis

5.3

Abcam

4.8

Anpario

3.2

MaxCyte

3.2

Avingtrans

2.9

Surface Transforms

2.7

Mattioli Woods

2.4

Access Intelligence

2.2

Directa Plus

2.0

 

 

Total

36.0

 

Share Buy-Backs

 

During the period from 1 April 2022 to 30 June 2022, the Company bought back 785,645 of its own Ordinary Shares for cancellation, at an average price of 164 pence per share excluding costs. As at 30 June 2022, there were 160,289,307 Ordinary Shares in issue.

 

Dividends

 

As advised in the Interim Report, the Board has declared an interim dividend of 3.0 pence per share in respect of the Company's half-year ended 31 March 2022. This interim dividend will be paid on 11 August 2022 to Shareholders who were on the register on 15 July 2022. In addition, following the receipt of proceeds due from the takeover of Interactive Investor by abrdn, the Board has decided to distribute the entire realised capital gain of £51.6 million by way of a Special Dividend of 32.0 pence per share, which will be paid alongside the interim dividend on 11 August.

 

 

Chris Hutchinson

Unicorn Asset Management

Investment Director

 

26 July 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRZZGZNGVLGZZM
Date   Source Headline
14th Dec 20227:00 amRNSFinal Results
8th Dec 202210:12 amRNSIntention to Launch an Offer
5th Dec 20222:43 pmRNSNet Asset Value(s)
4th Nov 20225:47 pmRNSNet Asset Value(s)
21st Oct 20221:38 pmRNSNet Asset Value(s)
3rd Oct 202212:45 pmRNSTotal Voting Rights
20th Sep 20226:19 pmRNSTransaction in Own Shares
5th Sep 202212:32 pmRNSNet Asset Value(s)
11th Aug 202211:27 amRNSIssue of Equity
4th Aug 20222:47 pmRNSNet Asset Value(s)
26th Jul 202211:30 amRNSInterim Management Statement
7th Jul 20229:50 amRNSNet Asset Value(s)
1st Jul 202210:00 amRNSTotal Voting Rights
22nd Jun 20225:44 pmRNSTransaction in Own Shares
14th Jun 20223:27 pmRNSNet Asset Value(s)
10th Jun 20227:00 amRNSHalf-year Report
24th May 20222:26 pmRNSDirectorate Change
6th May 202212:33 pmRNSNet Asset Value(s)
11th Apr 20229:02 amRNSNet Asset Value(s) Replacement
7th Apr 20223:14 pmRNSNet Asset Value(s)
1st Apr 202210:43 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20221:40 pmRNSDirector/PDMR Shareholding
4th Mar 202212:44 pmRNSTotal Voting Rights
4th Mar 202212:39 pmRNSIssue of Equity
2nd Mar 20222:26 pmRNSNet Asset Value(s)
1st Mar 20229:58 amRNSTotal Voting Rights
18th Feb 20221:27 pmRNSInterim Management Statement
15th Feb 20224:51 pmRNSTransaction in Own Shares
10th Feb 20227:00 amRNSIssue of Equity
9th Feb 202212:11 pmRNSOffer for Subscription - Update
7th Feb 202210:12 amRNSNet Asset Value(s)
3rd Feb 20221:34 pmRNSResult of AGM
1st Feb 202211:52 amRNSTotal Voting Rights
24th Jan 202210:17 amRNSOffer for Subscription and Issue of Prospectus
17th Jan 202212:44 pmRNSTransaction in Own Shares
6th Jan 20222:49 pmRNSNet Asset Value(s)
4th Jan 20229:41 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSTransaction in Own Shares
16th Dec 202112:33 pmRNSConfirmation of Dividends
14th Dec 20211:48 pmRNSNet Asset Value(s)
8th Dec 20217:00 amRNSFinal Results
22nd Nov 20215:07 pmRNSDeclaration of Special Dividend
4th Nov 20215:47 pmRNSNet Asset Value(s)
26th Oct 20213:07 pmRNSIntention to launch an Offer
18th Oct 20214:34 pmRNSNet Asset Value(s)
1st Oct 202111:46 amRNSTotal Voting Rights
10th Sep 20213:52 pmRNSTransaction in Own Shares
1st Sep 20212:46 pmRNSTotal Voting Rights
16th Aug 202110:57 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.